SLC5A2 and chronic kidney disease: Given that the positive, organ-specific influences of SGLT2 inhibitors are thought to be driven by pleiotropic effects, it becomes increasingly crucial to explore the intricate web of interactions between these agents and iron homeostasis within the context of HF and CKD.